Salivary gland disease in the era of COVID-19 pandemic.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 32343454.
- Also identified by DOI 10.1002/hed.26210 and PMC identifier 7267671.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Coronavirus disease 2019 (COVID-19) pandemic forced significant changes in current approach to outpatient evaluation of common otolaryngology complaints as hospitals around the world are trying to limit the spread of the virus and to preserve health care resources. These changes raise a lot of questions regarding patient triage and treatment decisions in clinical situations when it is unclear if the workup and management can be postponed. In this communication, we present our approach to evaluation and triage of new patients with complaints concerning for salivary gland disease.
Medical subject headings
- Betacoronavirus
- Coronavirus Infections
- Otolaryngology
- Pneumonia, Viral
- Salivary Gland Diseases
- Telemedicine
- Triage